A 37-year-old woman with psoriatic arthritis and undiagnosed liver disease showed significant reversal of liver fibro-inflammation after 6 months of IL-17A inhibitor (secukinumab) treatment. Quantitative mpMRI and blood tests confirmed improved liver health, suggesting biologic disease-modifying antirheumatic drugs may benefit coexisting metabolic liver disease and psoriatic disease.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?